Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Antiepileptic Drugs

Research Leaders

12 sponsors active, led by Université Libre de Bruxelles

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Research Network

Common Treatments

  • Antiepileptic Drugs1
  • No Antiepileptic Drugs1

Active Sponsors

  • Université Libre de Bruxelles1
  • Rijnstate Hospital1
  • VieCuri Medical Centre1
  • University Medical Center Groningen1
  • University of Twente1

Top Investigators

Related Conditions

  • Status Epilepticus1
  • Cardiac Arrest1

Activity Timeline